Anzeige
Mehr »
Login
Montag, 14.06.2021 Börsentäglich über 12.000 News von 662 internationalen Medien
Angehender Nickelproduzent mit 439 Mio. $ Gewinn pro Jahr!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XE6M ISIN: IE00BJ3V9050 Ticker-Symbol: EO7 
Tradegate
11.06.21
08:30 Uhr
4,843 Euro
-0,124
-2,50 %
1-Jahres-Chart
ENDO INTERNATIONAL PLC Chart 1 Jahr
5-Tage-Chart
ENDO INTERNATIONAL PLC 5-Tage-Chart
RealtimeGeldBriefZeit
5,1285,25013.06.
5,1185,21211.06.

Aktuelle News zur ENDO Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SaTennessee Court Of Appeals Issues Orders Regarding State Court Default Judgment Against Endo401DUBLIN, June 12, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that the Tennessee Court of Appeals recently issued several orders with respect to a default judgment...
► Artikel lesen
DoEndo International plc - 8-K, Current Report3
25.05.Endo International: Why Buy After The Drop28
ENDO Aktie jetzt für 0€ handeln
12.05.Endo to Participate at 2021 RBC Capital Markets Global Healthcare Virtual Conference290DUBLIN, May 12, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the 2021 RBC Capital Markets...
► Artikel lesen
07.05.Endo International's (ENDP) CEO Blaise Coleman on Q1 2021 Results - Earnings Call Transcript14
07.05.Endo's (ENDP) Earnings & Revenues Surpass Estimates in Q116
07.05.Endo International plc 2021 Q1 - Results - Earnings Call Presentation3
07.05.Endo International plc - 10-Q, Quaterly Report1
06.05.Endo International plc Q1 adjusted earnings Beat Estimates295WASHINGTON (dpa-AFX) - Endo International plc (ENDP) released a profit for first quarter that decreased from last year.The company's bottom line came in at $47.06 million, or $0.20 per share....
► Artikel lesen
06.05.Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance283DUBLIN, May 6, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2021. "I am proud of the continued strong...
► Artikel lesen
29.04.Endo International plc - 8-K, Current Report5
29.04.Endo's Qwo (collagenase clostridium histolyticum-aaes) Data to Be Presented at The Aesthetic Meeting 2021221DUBLIN, April 29, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that data relevant to the use of Endo Aesthetics' Qwo (collagenase clostridium histolyticum-aaes)...
► Artikel lesen
27.04.Endo International Implements Board Succession Plan488Mark Barberio appointed Chairman of the Board of Directors effective at 2021 Annual General Meeting DUBLIN, April 27, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo"...
► Artikel lesen
19.04.Johnson & Johnson, AbbVie, Teva and Endo to face pharma's first opioid trial since 2019181
14.04.Endo's Qwo shows 'meaningful improvement' in late-sage cellulite study in women13
13.04.Endo to Announce First Quarter 2021 Financial Results310DUBLIN, April 13, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2021 financial results on May 6, 2021 and members of its senior management team...
► Artikel lesen
13.04.Endo Announces Publication of Phase 3 Qwo (collagenase clostridium histolyticum-aaes) Data in Peer-Reviewed Dermatologic Surgery280 DUBLIN, April 13, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that Phase 3 data evaluating Qwo (collagenase clostridium histolyticum-aaes) for the treatment...
► Artikel lesen
12.04.Endo, Advanz Pharma Partner To Commercialize Xydalba In Canada321WASHINGTON (dpa-AFX) - Endo International plc (ENDP) said that its subsidiary, Endo Ventures Limited, has reached a definitive agreement with Correvio International Sàrl entity, a subsidiary...
► Artikel lesen
12.04.ADVANZ PHARMA and Endo Announce Partnership for Paladin Labs to Commercialize Xydalba (dalbavancin hydrochloride) in Canada5
08.04.Auris Medical, Prometheus Biosciences leads healthcare gainers; Endo International, Odonate Therapeutics among major losers26
Seite:  Weiter >>
95 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,4